Management of Hyperglycemia in the Critically Ill

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1904 times

Chapter 51 Management of Hyperglycemia in the Critically Ill

9 What is the appropriate glycemic target for critically ill patients?

Recognizing the importance of glycemic control in critically ill patients, a number of professional societies have developed treatment guidelines and/or consensus statements that provide evidence-based glycemic targets. Although the glycemic targets are not identical, all of the groups advocate for good glycemic control while avoiding hypoglycemia (see Table 51-1).

Table 51-1 Summary of glycemic targets from the medical literature

Professional society/consensus statement Glycemic target for critically ill patients
American Diabetes Association 140-180 mg/dL
American Association of Clinical Endocrinologists 140-180 mg/dL
Surviving Sepsis Campaign 150-180 mg/dL
American College of Physicians 140-200 mg/dL
American Thoracic Society <180 mg/dL (in patients undergoing cardiac surgery)

Bibliography

1 Clement S., Braithwaite S., Magee M., et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:856.

2 Cryer P., Davis S., Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–1912.

3 Dellinger R., Levy M., Carlet J., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:1394–1396.

4 Egi M., Bellomo R., Stachowski E., et al. Hypoglycemia and outcomes in critically ill patients. Mayo Clin Proc. 2010;85:217–224.

5 Egi M., Finfer S., Bellomo R. Glycemic control in the ICU. Chest. 2011;140:212–220.

6 Finfer S., Chittock D., Su S., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297. NICE-SUGAR Study Investigators;

7 Insucchi S. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;355:1903–1911.

8 Lazar H., McDonnnell M., Chipkin S., et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87:663–669.

9 Levetan C., Salas J., Wilets I., et al. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99:22–28.

10 McCowen K., Malhotra A., Bistrian B. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–124.

11 Moghissi E., Korytkowski M., DiNardo M., et al. AACE/ADA consensus statement on inpatient glycemic control. Endocr Pract. 2009;15(4):1–17.

12 Qaseem A., Humphrey L.L., Chou R., et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260–267.

13 Umpierrez G., Smiley M., Zisman A., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 Trial). Diabetes Care. 2007;30:2181–2186.

14 Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367.

15 Wiener R., Wiener D., Larson R. Benefits and risk of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300:933–944.